All seven independent directors of DNA-testing company 23andMe resigned, following a protracted negotiation with CEO Anne Wojcicki over her plan to take the company private.

Following a monthslong battle over CEO Anne Wojcicki’s plans to take 23andMe private, all seven independent members of its board resigned en masse Tuesday. The move is almost certainly the final nail in the coffin for the embattled company known for its mail-order DNA-testing kit.

The pioneering DNA testing firm has been struggling to stay afloat financially despite ambitious ventures to provide health care and develop pharmaceuticals.

Nearly the entire board of directors for 23andMe has resigned — a move that apparently was news to its overly-optimistic chief executive.

Me's entire board of directors resigned over cofounder and CEO Anne Wojcicki's ongoing plan to take it private.

The biotech company 23andMe has a big mess to clean up after its entire board resigned to protest its CEO’s plans to take the genetic-testing company private. The stock is down more than 63% so far this year,

The company’s revenue and share price has shrunk so much, it may soon be ineligible for listing on the Nasdaq index.

Ann Wojcicki, CEO and co-founder of 23andMe, says she is still planning to take the genetic-testing company private despite the resignation this week of the entire board of directors. "After months of work,